Navigation Links
BIO-key(R) Awarded PocketCop(R) Contracts From Major Law Enforcement Agencies
Date:11/3/2008

ushek, the Baltimore Police Department's mobile data system administrator. At a known gang activity or drug location, for example, undercover officers and investigators can run a license plate to identify the driver and make sure the vehicle hasn't been reported as stolen. "Because BlackBerry smartphones are everywhere now, an undercover officer using one while on surveillance doesn't draw attention," Zapushek observed.

"These enterprise-level deployments are further evidence that PocketCop has taken hold across the country and become the standard for mobile data on BlackBerry smartphones," stated Michael DePasquale, BIO-key's Chief Executive Officer. BIO-key is a member of the BlackBerry(R) ISV Alliance program.

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases. BIO-key's high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise data to improve security, convenience and privacy and to reduce identity theft. Over 750 police departments in North America use BIO-key solutions, making BIO-key the leading supplier of mobile and wireless solutions for law enforcement. (http://www.bio-key.com)

Company Contact: BIO-key International, Inc.

Bud Yanak

732-359-1100


'/>"/>
SOURCE BIO-key International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology news :

1. identiMetrics & BIO-key(R) Provide Biometric Finger Scanning for School Food Service Nationwide
2. BIO-key(R) Granted Additional Patent for Biometric Security Solution
3. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
4. Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency
5. Parente Randolph Secures Access to New Corporate Headquarters With BIO-key(R) Biometric Identification
6. BIO-key(R) to Showcase Biometric Security Applications at 2008 Biometric Technology Expo
7. BIO-key(R) International To Exhibit at Oracle OpenWorld
8. BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses
9. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
10. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
11. BIO-key(R) Issues Open Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4